Market Snapshot

BSE Sensex: 75527.95 2.30%
BSE 500: 35342.5 2.20%
BSE 200: 11009.02 2.14%
BSE 100: 25089.37 2.11%
BSE BANKEX: 63987.8 2.94%
BSE IT: 27167.9 0.39%
Nifty 50: 23622.9 1.99%
Nifty 500: 22599.8 2.19%
Nifty 200: 13618.55 2.14%
Nifty 100: 24602.25 2.06%
Nifty Midcap 100: 60768.1 2.43%
Nifty Small 100: 18197.45 2.80%
Nifty IT: 27795.75 -0.09%
Nifty PSU Bank: 8528.75 2.71%

News:

RBL Bank appoints Bhavin Lakhp...
BHEL bags over Rs 90-cr LNTP f...
Fractal Analytics ends higher ...
Mahindra EPC Irrigation bags R...
DOMS Inds surges after inking ...

Dishman Carbogen Amcis Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

12 Jun 2026 | 03:59 PM

184.45

7.60 (4.30%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-34%

Return (1Y)

Underperformed BSE Healthcare by 41.79%
More Volatile

3.41%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.56%
Not so consistent

6/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

321

129

News & Announcements

Dishman Carbogen Amcis EGM scheduled
15 days ago

Dishman Carbogen Amcis EGM scheduled

29 - May - 2026 12:00 | 15 days ago

Dishman Carbogen Amcis announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 19 June 2026.

Dishman Carbogen Amcis consolidated net profit declines 49.55% in the March 2026 quarter

24 days ago

Dishman Carbogen Amcis to announce Quarterly Result
29 days ago

Dishman Carbogen Amcis to announce Quarterly Result

15 - May - 2026 12:00 | 29 days ago

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 19 May 2026.
Dishman Carbogen Amcis reports consolidated net loss of Rs 12.97 crore in the December 2025 quarter
129 days ago

Dishman Carbogen Amcis reports consolidated net loss of Rs 12.97 crore in the December 2025 quarter

04 - Feb - 2026 12:00 | 129 days ago

Net loss of Dishman Carbogen Amcis reported to Rs 12.97 crore in the quarter ended December 2025 as against net profit of Rs 4.63 crore during the previous quarter ended December 2024. Sales rose 5.49% to Rs 719.80 crore in the quarter ended December 2025 as against Rs 682.34 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 719.80 682.34 5

OPM % 15.71 20.54 -

PBDT 73.98 96.98 -24

PBT -10.44 25.01 PL

NP -12.97 4.63 PL

Powered by Capital Market - Live News

Stock Trivia

FII shareholding in Dishman Carbogen Amcis Ltd has decreased by -21.53% since past 1 Year
Dishman Carbogen Amcis Ltd has the Lowesr P/E ratio according to FY 202603 data among stocks in Pharmaceuticals Sector
Dishman Carbogen Amcis Ltd has the Lowesr P/B ratio according to FY 202603 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60